In the past year, coronavirus disease 2019 (COVID-19) has presented unique challenges to rheumatology practices and care. Although not at the frontline, rheumatologists have had to face difficult decisions regarding, and not limited to, immunosuppressant management and the continuity of care for patients. But with the COVID-19 vaccines at the helm, what does the current rheumatology landscape look like and what is potentially in store for the future of patient care?
Continue Reading
In this episode, Amit Ladani, MD, a rheumatologist at West Virginia University Hospital, gives us his perspective on the impact of COVID-19 on rheumatology.
Editor’s Note: Please note that this episode was developed and edited before the American College of Rheumatology (ACR) released clinical guidance regarding COVID-19 vaccines in patients with rheumatic and musculoskeletal diseases. We will be providing updated information soon.
Featured Guest
Amit P. Ladani, MBBS, MD, came to the United States in 2010 after practicing internal medicine in India for about 9 years. He completed his residency in internal medicine at UPMC Mercy Hospital in Pittsburgh, Pennsylvania, and his fellowship in rheumatology at the University of Massachusetts in Worcester.
Dr Ladani worked at Indiana Regional Medical Center (IRMC) for 3.5 years, where he was an adjunct assistant professor at Lake Erie College of Osteopathic Medicine (LECOM) and served as the medical director of rheumatology care services. Dr Ladani joined West Virginia University in January 2019 as an assistant professor, where he currently also serves as the director of research in the Division of Rheumatology.
Dr Ladani has an immense interest in the interplay between autoimmune rheumatic diseases and infectious agents, and wants to explore their association, which will help understand the etiopathology of many autoimmune rheumatic diseases.
Enjoying our content?
Thanks for visiting Rheumatology Advisor. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Rheumatology Advisor. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.